Lamotrigine Tablet, Extended Release
Product Images NDC 55111-428

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 55111-428). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

FDA Label Image

Container2 (Container2)

FDA Label Image

Container3 (Container3)

FDA Label Image

Container4 (Container4)

FDA Label Image

Container5

Container5
Lamotrigine Extended-Release Tablets USP 250 mg is a medication prescribed for the treatment of seizures in patients suffering from epilepsy. This medication comes in a tablet form, and each tablet contains 250 mg of the active ingredient. The extended-release tablets are designed to release the medication slowly in the body, which helps to maintain a steady level of medicine in the blood and reduces the risk of side effects. Note that the text contains some errors and non-English characters.*
FDA Label Image

Container6 (Container6)

Container6 (Container6)
Dr. Reddy's Laboratories Limited is a pharmaceutical company that produces Lamotrigine Extended-Release tablets with a strength of 300 mg. Unfortunately, the rest of the text is not available as it seems to have been incorrectly recognized by the software.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
This appears to be a graph depicting the responder rates, improvement, and worsening of patients taking placebo and Lametrigine ER Tablets. The percentages displayed on the Y-axis range from -100% to 75%, while the X-axis shows the different categories of responders, improved patients, and worsened patients. The numbers in the graph represent the percentage of patients falling under each category.*
FDA Label Image

Figure2 (Figure2)

FDA Label Image

Pictures (Pictures)

Pictures (Pictures)
This is a list of different medication options with varying dosages, colors, and imprints for identification. The medications come in tablet and capsule form, and are imprinted with different codes for easy identification by medical professionals.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.